These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23662108)

  • 21. [Half a century of newborn screening in Spain: Evolution of ethical, legal and social issues (ELSIs). Part III, social issues.].
    Labrador Cañadas MV; Pàmpols Ros T; Dulín Íñiguez E; Pérez Aytés A; García Sagredo JM; Díaz de Bustamante A; Martín Arribas C; García López FJ; Nicolás Jiménez P
    Rev Esp Salud Publica; 2021 Jan; 95():. PubMed ID: 33496273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
    Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
    JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethical, Legal, and Social Implications of Personalized Genomic Medicine Research: Current Literature and Suggestions for the Future.
    Callier SL; Abudu R; Mehlman MJ; Singer ME; Neuhauser D; Caga-Anan C; Wiesner GL
    Bioethics; 2016 Nov; 30(9):698-705. PubMed ID: 27767224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
    Iijima K; Arai H; Akishita M; Endo T; Ogasawara K; Kashihara N; Hayashi YK; Yumura W; Yokode M; Ouchi Y
    Geriatr Gerontol Int; 2021 Aug; 21(8):601-613. PubMed ID: 34212470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic medicine: what are the challenges for the National Health Service?
    Skirton H; Jackson L; Goldsmith L; O'Connor A
    Per Med; 2012 Jul; 9(5):539-545. PubMed ID: 29768768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic/genomic testing: defining the parameters for ethical, legal and social implications (ELSI).
    Ascencio-Carbajal T; Saruwatari-Zavala G; Navarro-Garcia F; Frixione E
    BMC Med Ethics; 2021 Nov; 22(1):156. PubMed ID: 34814901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects.
    Shoaib M; Rameez MAM; Hussain SA; Madadin M; Menezes RG
    Sci Eng Ethics; 2017 Aug; 23(4):1207-1212. PubMed ID: 27896605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. personalized medicine and pharmacogenomics: ethical and social challenges.
    Lee SS
    Per Med; 2005 Mar; 2(1):29-35. PubMed ID: 29793238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donald A. B. Lindberg: Inspiring Leader and Visionary in Biomedicine, Healthcare, and Informatics.
    Kulikowski CA
    Yearb Med Inform; 2020 Aug; 29(1):253-258. PubMed ID: 32303093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re-focusing the ethical discourse on personalized medicine: a qualitative interview study with stakeholders in the German healthcare system.
    Schleidgen S; Marckmann G
    BMC Med Ethics; 2013 May; 14():20. PubMed ID: 23705623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Status and perspectives of biomarker validation for diagnosis, stratification, and treatment.
    Skov J; Kristiansen K; Jespersen J; Olesen P
    Public Health; 2021 Jan; 190():173-175. PubMed ID: 33309006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethical concerns caused by integrative patient empowerment solutions for personalized medicine.
    Kuchinke W
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():4775-8. PubMed ID: 24110802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From evidence-based medicine to genomic medicine.
    Kumar D
    Genomic Med; 2007; 1(3-4):95-104. PubMed ID: 18923934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Participatory Genomic Research: Ethical Issues from the Bottom Up to the Top Down.
    Aungst H; Fishman JR; McGowan ML
    Annu Rev Genomics Hum Genet; 2017 Aug; 18():357-367. PubMed ID: 28426284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical decision-making and secondary findings in systems medicine.
    Fischer T; Brothers KB; Erdmann P; Langanke M
    BMC Med Ethics; 2016 May; 17(1):32. PubMed ID: 27209083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translation in Data Mining to Advance Personalized Medicine for Health Equity.
    Estape ES; Mays MH; Sternke EA
    Intell Inf Manag; 2016 Jan; 8(1):9-16. PubMed ID: 27195185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
    Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
    Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Other side of the coin for personalised medicine and healthcare: content analysis of 'personalised' practices in the literature.
    Cesuroglu T; Syurina E; Feron F; Krumeich A
    BMJ Open; 2016 Jul; 6(7):e010243. PubMed ID: 27412099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcare.
    Simmons LA; Dinan MA; Robinson TJ; Snyderman R
    Per Med; 2012 Jan; 9(1):85-91. PubMed ID: 29783292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artificial Intelligence in Healthcare and Medicine: Promises, Ethical Challenges and Governance.
    Guan J
    Chin Med Sci J; 2019 Jun; 34(2):76-83. PubMed ID: 31315747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.